Reducing Dietary Sodium to 1000 mg per Day Reduces Neurovascular Transduction Without Stimulating Sympathetic Outflow.
Adult
Blood Pressure
/ physiology
Cross-Over Studies
Diet, Sodium-Restricted
/ methods
Dose-Response Relationship, Drug
Female
Humans
Hypertension
/ drug therapy
Male
Muscle, Smooth, Vascular
/ innervation
Sodium Chloride, Dietary
/ administration & dosage
Sympathetic Nervous System
/ physiopathology
Vascular Resistance
/ physiology
Young Adult
aldosterone
angiotensins
blood pressure
hypertension
renin
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
22
1
2019
medline:
15
11
2019
entrez:
22
1
2019
Statut:
ppublish
Résumé
The American Heart Association recommends no more than 1500 mg of sodium/day as ideal. Some cohort studies suggest low-sodium intake is associated with increased cardiovascular mortality. Extremely low-sodium diets (≤500 mg/d) elicit activation of the renin-angiotensin-aldosterone system and stimulate sympathetic outflow. The effects of an American Heart Association-recommended diet on sympathetic regulation of the vasculature are unclear. Therefore, we assessed whether a 1000 mg/d diet alters sympathetic outflow and sympathetic vascular transduction compared with the more commonly recommended 2300 mg/d. We hypothesized that sodium reduction from 2300 to 1000 mg/d would not affect resting sympathetic outflow but would reduce sympathetic transduction in healthy young adults. Seventeen participants (age: 26±2 years, 9F/8M) completed 10-day 2300 and 1000 mg/d sodium diets in this randomized controlled feeding study (crossover). We measured resting renin activity, angiotensin II, aldosterone, blood pressure, muscle sympathetic nerve activity, and norepinephrine. We quantified beat-by-beat changes in mean arterial pressure and leg vascular conductance (femoral artery ultrasound) following spontaneous sympathetic bursts to assess sympathetic vascular transduction. Reducing sodium to 1000 mg/d increased renin activity, angiotensin II, and aldosterone ( P<0.01 for all) but did not alter mean arterial pressure (78±2 versus 77±2 mm Hg, P=0.56), muscle sympathetic nerve activity (13.9±1.3 versus 13.9±0.8 bursts/min, P=0.98), or plasma/urine norepinephrine. Sympathetic vascular transduction decreased ( P<0.01). These data suggest that reducing sodium from 2300 to 1000 mg/d stimulates the renin-angiotensin-aldosterone system, does not increase resting basal sympathetic outflow, and reduces sympathetic vascular transduction in normotensive adults.
Identifiants
pubmed: 30661474
doi: 10.1161/HYPERTENSIONAHA.118.12074
pmc: PMC6374182
mid: NIHMS1517647
doi:
Substances chimiques
Sodium Chloride, Dietary
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
587-593Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM113125
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128388
Pays : United States
Références
Circulation. 2014 Mar 11;129(10):1173-86
pubmed: 24515991
Lancet. 2011 Jul 30;378(9789):380-2
pubmed: 21803192
Hypertension. 1989 Aug;14(2):177-83
pubmed: 2759678
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2960-84
pubmed: 24239922
BMJ. 2013 Apr 03;346:f1325
pubmed: 23558162
J Am Coll Cardiol. 2015 Mar 17;65(10):1042-50
pubmed: 25766952
J Am Heart Assoc. 2017 Oct 19;6(10):
pubmed: 29051214
Lancet. 2018 Aug 11;392(10146):496-506
pubmed: 30129465
Hypertension. 2015 Oct;66(4):850-7
pubmed: 26259596
Am J Hypertens. 2014 Sep;27(9):1129-37
pubmed: 24651634
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):990-5
pubmed: 24989702
J Physiol. 2008 Feb 15;586(4):1137-45
pubmed: 18096601
Hypertension. 1997 Mar;29(3):802-7
pubmed: 9052899
Am J Physiol Heart Circ Physiol. 2017 May 1;312(5):H1031-H1051
pubmed: 28364017
J Auton Nerv Syst. 1982 Nov;6(3):293-302
pubmed: 7169499
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):554-65
pubmed: 24821105
Acta Physiol Scand Suppl. 1990;591:48-62
pubmed: 2220409
J Physiol. 2013 Jul 15;591(14):3637-49
pubmed: 23652594
Auton Neurosci. 2009 Jun 15;148(1-2):5-15
pubmed: 19268634
Am J Physiol Heart Circ Physiol. 2013 Mar 1;304(5):H759-66
pubmed: 23292718
Compr Physiol. 2014 Apr;4(2):825-50
pubmed: 24715570
J Hum Hypertens. 2002 Dec;16(12):843-50
pubmed: 12522465
J Am Coll Cardiol. 2016 Oct 11;68(15):1609-1617
pubmed: 27712772
Am J Hypertens. 2014 Jun;27(6):801-10
pubmed: 24436325
MMWR Morb Mortal Wkly Rep. 2010 Jun 25;59(24):746-9
pubmed: 20577156
J Clin Invest. 2017 May 1;127(5):1932-1943
pubmed: 28414302
BMJ. 2009 Nov 24;339:b4567
pubmed: 19934192
Medicine (Baltimore). 2017 Feb;96(8):e6000
pubmed: 28225488
J Hypertens. 2013 Mar;31(3):530-6
pubmed: 23263240
Am J Clin Nutr. 2010 Nov;92(5):1172-80
pubmed: 20826631
J Appl Physiol (1985). 2015 Jun 15;118(12):1510-5
pubmed: 26078434
Circ Res. 1976 Jun;38(6):477-83
pubmed: 773568
Hypertension. 2018 Jan;71(1):192-198
pubmed: 29203629
JAMA. 2011 May 4;305(17):1777-85
pubmed: 21540421
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
J Physiol. 2012 Nov 1;590(21):5519-28
pubmed: 22907057
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Hypertension. 1990 Aug;16(2):121-30
pubmed: 2379945
Hypertens Res. 2016 Mar;39(3):119-26
pubmed: 26399454
Circulation. 2012 Dec 11;126(24):2880-9
pubmed: 23124030